Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RESLIZUMAB vs RESTASIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RESLIZUMAB vs RESTASIS: Safety Overview

Metric RESLIZUMAB RESTASIS
Total FAERS Reports 621 1,158
Deaths Reported 15 0
Death Rate 2.4% N/A
Hospitalizations 121 5
Average Patient Age 55.9 yrs 66.9 yrs
% Female Patients 63.2% N/A
Manufacturer Teva Respiratory, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A